REVIEW Tulobuterol is a long-acting beta2-adrenergic receptor agonist,which acts as a bronchodilator, marketed in Japan as a transdermal patch under the name Hokunalin tape. This is the first bronchodilator to be available as a transdermal patch, and isused in the treatment of chronic obstructive lung disease.
Kubo, S.; Kase, Y.; Miyata, T.; Kito, G.; Uesaka, I. Pharmacological studies of 1-(o-chlorophenyl)-2-tert-butylaminoethanol (C-78), a new bronchodilator. Arzneimittel-Forschung (1975), 25(7), 1028-37.
Bogan, J. A. Tulobuterol hydrochloride. Drugs of Today (1982), 18(5), 238-43.
Patel KR. Tulobuterol in the management of obstructive airways disease in adults. Clin Ther. 1985;7(4):452-67.
Kato H, Nagata O, Yamazaki M, Suzuki T, Nakano Y. Yakugaku Zasshi. Development of transdermal formulation of tulobuterol for the treatment of bronchial asthma. 2002 Jan;122(1):57-69.
These chemical products are for research and development use only. They are not for diagnostic, therapeutic, cosmetic, or human and animal uses. They are not sold to individuals. Additional restrictions may apply.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. CATEGORIES APIs and Bioactives > Adrenergic Agonists